Low dose naltrexone therapy in multiple sclerosis
- 31 December 2005
- journal article
- Published by Elsevier BV in Medical Hypotheses
- Vol. 64 (4), 721-724
- https://doi.org/10.1016/j.mehy.2004.09.024
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damageJournal of Neuroimmunology, 2004
- Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosisClinical Neurology and Neurosurgery, 2004
- Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesionJournal of Neuroimmunology, 2004
- Pathogenesis of multiple sclerosis: The eyes only see what the mind is prepared to comprehendAnnals of Neurology, 2004
- Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesionAnnals of Neurology, 2004
- The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapyZeitschrift für Neurologie, 2004
- Nitric oxide synthase expression and enzymatic activity in multiple sclerosisActa Neurologica Scandinavica, 2004
- Shared scheme for assessing drugs for multiple sclerosis: Why are eyes tightly shut to considering causes other than autoimmunity?BMJ, 2003
- Fas ligand-mediated apoptosis in degenerative disorders of the brain.Journal of Clinical Immunology, 2003
- Peroxynitrite Inhibits Glutamate Transporter SubtypesOnline Journal of Public Health Informatics, 1996